| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $3.61 | $3.12 | $3.08 | $2.37 | $1.98 | $1.88 | $1.84 | $1.54 |
| EPS (Diluted) | $3.60 | $3.12 | $3.07 | $2.36 | $1.98 | $1.88 | $1.83 | $1.54 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.4B | $4.3B | $4.3B | $4.5B | $4.3B | $3.8B | $3.1B | $3.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $3.8B | $3.8B | $3.9B | $4.1B | $3.9B | $3.5B | $2.8B | $2.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.6B | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $-0.0B | $0.1B | — |
| Investing Cash Flow | $0.1B | $0.1B | $-0.1B | $-0.7B | $-0.4B | $-0.0B | $-0.0B | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.0B | $-0.1B | $-0.3B | $0.2B | $0.4B | $0.6B | $0.1B | — |